Histopathology of erythromelalgia in thrombocythaemia
- PMID: 6384014
- DOI: 10.1111/j.1365-2559.1984.tb02379.x
Histopathology of erythromelalgia in thrombocythaemia
Abstract
Erythromelalgia always appears to be an expression of thrombocythaemia which may be provoked by intravascular platelet aggregation, because it is relieved by agents interfering with platelet prostaglandin synthesis. Biopsies were taken from affected areas 1-3 weeks after discontinuation of aspirin. At that time arteriolar changes were present: the endothelial cells were often swollen with large nuclei. Narrowing of the lumen occurred by proliferation of smooth muscle cells with vacuolisation and swelling of the cytoplasm and deposition of intercellular material. The internal elastic lamina appeared to be split between the proliferated cells. This gave rise to the appearances of fibromuscular intimal arteriolar proliferation which were often occluded by thrombi of differing age. Ultimately the arterioles become completely fibrosed. These vascular changes are restricted to arterioles, are partly reversible with aspirin treatment and seem to be a characteristic of erythromelalgia.
Similar articles
-
Erythromelalgia caused by platelet-mediated arteriolar inflammation and thrombosis in thrombocythemia.Ann Intern Med. 1985 Apr;102(4):466-71. doi: 10.7326/0003-4819-102-4-466. Ann Intern Med. 1985. PMID: 3977194
-
[Histopathologic lesions in erythromelalgia during essential thrombocythemia].Ann Pathol. 1993;13(2):128-30. Ann Pathol. 1993. PMID: 8363673 French.
-
A case of secondary erythromelalgia with unusual histological findings.Am J Dermatopathol. 2013 Jun;35(4):489-90. doi: 10.1097/DAD.0b013e31827eaee9. Am J Dermatopathol. 2013. PMID: 23334520
-
Platelet-mediated thrombotic complications in patients with ET: Reversal by aspirin, platelet reduction, and not by coumadin.Blood Cells Mol Dis. 2006 Mar-Apr;36(2):199-205. doi: 10.1016/j.bcmd.2005.12.021. Epub 2006 Feb 28. Blood Cells Mol Dis. 2006. PMID: 16510297 Review.
-
Erythromelalgia and myeloproliferative disorders.Arch Intern Med. 1989 Jan;149(1):105-9. Arch Intern Med. 1989. PMID: 2643412 Review.
Cited by
-
Clinical Challenges in Primary Erythromelalgia: a Real-Life Experience from a Single Center and a Diagnostic-Therapeutic Flow-Chart Proposal.Dermatol Pract Concept. 2023 Jul 1;13(3):e2023191. doi: 10.5826/dpc.1303a191. Dermatol Pract Concept. 2023. PMID: 37557164 Free PMC article.
-
2016 WHO Clinical Molecular and Pathological Criteria for Classification and Staging of Myeloproliferative Neoplasms (MPN) Caused by MPN Driver Mutations in the JAK2, MPL and CALR Genes in the Context of New 2016 WHO Classification: Prognostic and Therapeutic Implications.Maedica (Bucur). 2016 Mar;11(1):5-25. Maedica (Bucur). 2016. PMID: 28465746 Free PMC article.
-
Acute secondary erythermalgia and hypertension in children. Erythermalgia Multidisciplinary Study Group.Eur J Pediatr. 1995 Nov;154(11):882-5. doi: 10.1007/BF01957497. Eur J Pediatr. 1995. PMID: 8582398
-
Recombinant interferon-alpha, but not interferon-gamma is effective therapy for essential thrombocythemia.Blut. 1990 Jan;60(1):37-40. doi: 10.1007/BF01720201. Blut. 1990. PMID: 2105111
-
Primary thrombocythemia: diagnosis, clinical manifestations and management.Ann Hematol. 1993 Aug;67(2):57-62. doi: 10.1007/BF01788127. Ann Hematol. 1993. PMID: 8347730 Review. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical